Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 31;62(5):513-517.
doi: 10.3325/cmj.2021.62.513.

Diagnostic validation of two SARS-CoV-2 immunochromatographic tests in Slovenian and Croatian hospitals

Affiliations

Diagnostic validation of two SARS-CoV-2 immunochromatographic tests in Slovenian and Croatian hospitals

Martina Ifko et al. Croat Med J. .

Abstract

Aim: To diagnostically validate two point-of-care (POC) rapid antigen tests for SARS-CoV-2 by comparing their results with those of laboratory-based real-time polymerase chain reaction tests (RT-PCR).

Methods: The study enrolled 455 patients from two Slovenian and two Croatian hospitals. The NADAL COVID-19 Ag Test (Nal von Minden, Moers, Germany) and ALLTEST COVID-19 Antigen Test (Hangzhou ALLTEST Biotech Co., Ltd, Hangzhou, China) were diagnostically validated in emergency care departments of two Slovenian hospitals, while only ALLTEST COVID-19 Antigen Test was validated in two Croatian hospitals.

Results: The antigen test results were in very good agreement with the RT-PCR results (Cohen's Kappa between 0.747 and 0.891 for the NADAL COVID-19 and between 0.820 and 0.954 for the ALLTEST COVID-19). The NADAL COVID-19 Ag Test had the sensitivity between 66.67% and 92.31%, with a negative predictive value between 85.51% and 99.2%. The ALLTEST COVID-19 Antigen Test had the sensitivity between 81.39% and 91.11%, with a negative predictive value between 85.45% and 98.78%.

Conclusion: The antigen tests are practical and reliable screening assays for SARS CoV-2 in emergency care departments. Both antigen tests can be used as screening tests to reduce the number of patients waiting for RT-PCR results. Even more, they can be used to quickly isolate COVID-19 patients and reduce hospital transmissions.

PubMed Disclaimer

References

    1. European Commission. Coronavirus resurgence: Commission steps up action to reinforce preparedness and response measures across the EU. Available from: https://ec.europa.eu/health/sites/health/files/preparedness_response/doc.... Accessed: October 28, 2020.
    1. Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DKW, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045. - DOI - PMC - PubMed
    1. European Centre for Disease Prevention and Control (ECDC). Diagnostic testing and screening for SARS-CoV-2. Available from: https://www.ecdc.europa.eu/en/covid-19/latest-evidence/diagnostic-testing. Accessed: October 28, 2020.
    1. World Health Organisation (WHO). Antigen-detection in the diagnosis of SARS-CoV-2 infection using rapid immunoassays. Interim guidance. September 11, 2020. Available from: https://www.who.int/publications/i/item/antigen-detection-in-the-diagnos.... Accessed: September 11, 2020.
    1. SLEDILNIK Covid-19 tracker. Available from: https://covid-19.sledilnik.org/en/stats. Accessed: December 12, 2020.